ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Bernard M.Y. Cheung
Matched on ORCID iD 0000-0001-9106-7363; OpenAlex author ID A5113918967. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 2 papers
Papers 2
- Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4… Co-author DOI 10.1016/j.deman.2022.100115↗
- Incidence of pancreatic cancer in angiotensin-converting enzyme inhibitors (ACEIs) versus angiotensin receptor blockers (ARBs): a population-based cohort study Last author DOI 10.1101/2022.07.26.22278092↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gary Tse · 2 shared papers, 2022 · strength 0.28
- Paper Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors … DOI 10.1016/j.deman.2022.100115↗
- Paper Incidence of pancreatic cancer in angiotensin-converting enzyme inhibitors (ACEIs) versus angiotensin receptor blockers… DOI 10.1101/2022.07.26.22278092↗
- Sharen Lee · 2 shared papers, 2022 · strength 0.28
- Paper Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors … DOI 10.1016/j.deman.2022.100115↗
- Paper Incidence of pancreatic cancer in angiotensin-converting enzyme inhibitors (ACEIs) versus angiotensin receptor blockers… DOI 10.1101/2022.07.26.22278092↗
- Edward Christopher Dee · 1 shared paper, 2022 · strength 0.14
- Oscar Hou In Chou · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.